Stopa, Victoria
Lileikyte, Gabriele
Bakochi, Anahita
Agarwal, Prasoon
Beske, Rasmus
Stammet, Pascal
Hassager, Christian
Årman, Filip
Nielsen, Niklas
Devaux, Yvan https://orcid.org/0000-0002-5321-8543
Funding for this research was provided by:
Horizon 2020 Framework Programme (101016072)
Fonds National de la Recherche Luxembourg (C14/BM/8225223, C17/BM/11613033, COVID-19/2020-1/14719577/miRCOVID)
Ministère de l'Education Nationale, de la Formation professionnelle, de l'Enseignement Supérieur et de la Recherche Scientifique
Heart Foundation-Daniel Wagner (YMCA project)
Novo Nordisk
Lundbeck Foundation
The Danish Heart Foundation
Article History
Received: 20 June 2024
Accepted: 11 September 2024
First Online: 27 September 2024
Declarations
:
: Not applicable.
: All authors consent for the publication of this manuscript.
: Y.D. holds patents and licensing agreements related to the use of RNAs for diagnostic and therapeutic purposes, and is member of the Scientific Advisory Board of Firalis SA. Other authors declare no competing interests.